News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,104 Results
Type
Article (12102)
Company Profile (127)
Press Release (306866)
Multimedia
Podcasts (31)
Webinars (9)
Section
Business (102030)
Career Advice (748)
Deals (17189)
Drug Delivery (57)
Drug Development (25269)
Employer Resources (39)
FDA (5370)
Job Trends (7705)
News (152580)
Policy (12572)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (3)
Academia (1334)
Academic (1)
Accelerated approval (8)
Adcomms (8)
Allergies (54)
Alliances (30842)
ALS (54)
Alzheimer's disease (666)
Antibody-drug conjugate (ADC) (107)
Approvals (5502)
Artificial intelligence (372)
Autoimmune disease (66)
Automation (24)
Bankruptcy (139)
Best Places to Work (6598)
BIOSECURE Act (12)
Biosimilars (74)
Biotechnology (83)
Bladder cancer (42)
Brain cancer (19)
Breast cancer (235)
Cancer (1953)
Cardiovascular disease (142)
Career advice (647)
Career pathing (19)
CAR-T (91)
CDC (34)
Celiac Disease (1)
Cell therapy (278)
Cervical cancer (12)
Clinical research (21397)
Collaboration (1104)
Company closure (3)
Compensation (693)
Complete response letters (13)
COVID-19 (904)
CRISPR (43)
C-suite (432)
Cystic fibrosis (54)
Data (2377)
Decentralized trials (1)
Denatured (11)
Depression (48)
Diabetes (164)
Diagnostics (3751)
Digital health (26)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (221)
Drug pricing (113)
Drug shortages (6)
Duchenne muscular dystrophy (72)
Earnings (36099)
Editorial (24)
Employer branding (3)
Employer resources (36)
Events (43403)
Executive appointments (556)
FDA (6637)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (690)
Gene editing (66)
Generative AI (31)
Gene therapy (203)
GLP-1 (342)
Government (2503)
Grass and pollen (5)
Guidances (236)
Healthcare (10560)
HIV (26)
Huntington's disease (18)
IgA nephropathy (14)
Immunology and inflammation (62)
Immuno-oncology (24)
Indications (39)
Infectious disease (1001)
Inflammatory bowel disease (91)
Inflation Reduction Act (12)
Influenza (39)
Intellectual property (82)
Interviews (112)
IPO (7611)
IRA (36)
Job creations (1336)
Job search strategy (547)
JPM (16)
Kidney cancer (4)
Labor market (51)
Layoffs (170)
Leadership (8)
Legal (2483)
Liver cancer (23)
Longevity (7)
Lung cancer (257)
Lymphoma (157)
Machine learning (31)
Management (11)
Manufacturing (475)
MASH (45)
Medical device (5462)
Medtech (5487)
Mergers & acquisitions (10124)
Metabolic disorders (397)
Multiple sclerosis (41)
NASH (3)
Neurodegenerative disease (110)
Neuropsychiatric disorders (17)
Neuroscience (1123)
NextGen: Class of 2026 (3781)
Non-profit (2976)
Now hiring (20)
Obesity (162)
Opinion (107)
Ovarian cancer (51)
Pain (65)
Pancreatic cancer (73)
Parkinson's disease (118)
Partnered (21)
Patents (159)
Patient recruitment (149)
Peanut (21)
People (31451)
Pharmaceutical (25)
Pharmacy benefit managers (16)
Phase 1 (7215)
Phase 2 (9008)
Phase 3 (6778)
Pipeline (2486)
Policy (174)
Postmarket research (680)
Preclinical (3425)
Press Release (70)
Prostate cancer (97)
Psychedelics (16)
Radiopharmaceuticals (137)
Rare diseases (278)
Real estate (3703)
Recruiting (18)
Regulatory (9318)
Reports (20)
Research institute (1468)
Resumes & cover letters (102)
Rett syndrome (3)
RNA editing (7)
RSV (23)
Schizophrenia (66)
Series A (104)
Series B (75)
Service/supplier (13)
Sickle cell disease (40)
Special edition (9)
Spinal muscular atrophy (88)
Sponsored (23)
Startups (1793)
State (1)
Supply chain (58)
Tariffs (23)
The Weekly (20)
Vaccines (279)
Venture capital (32)
Weight loss (82)
Women's health (36)
Worklife (6)
Date
Last 7 days (262)
Last 30 days (893)
Last 365 days (12942)
2026 (1268)
2025 (13175)
2024 (16173)
2023 (18875)
2022 (26301)
2021 (27528)
2020 (27119)
2019 (25659)
2018 (19376)
2017 (14750)
2016 (14081)
2015 (15835)
2014 (11449)
2013 (9614)
2012 (10545)
2011 (11252)
2010 (10093)
Location
Africa (303)
Alabama (31)
Alaska (5)
Arizona (104)
Arkansas (9)
Asia (17218)
Australia (2507)
California (4518)
Canada (1978)
China (556)
Colorado (256)
Connecticut (235)
Delaware (231)
Europe (42311)
Florida (622)
Georgia (131)
Hawaii (2)
Idaho (26)
Illinois (457)
India (35)
Indiana (357)
Iowa (7)
Japan (207)
Kansas (44)
Kentucky (25)
Louisiana (18)
Maine (32)
Maryland (809)
Massachusetts (3562)
Michigan (145)
Minnesota (217)
Mississippi (3)
Missouri (85)
Montana (22)
Nebraska (14)
Nevada (40)
New Hampshire (29)
New Jersey (1179)
New Mexico (18)
New York (1131)
North Carolina (707)
North Dakota (7)
Northern California (2251)
Ohio (174)
Oklahoma (14)
Oregon (13)
Pennsylvania (976)
Puerto Rico (13)
Rhode Island (27)
South America (473)
South Carolina (12)
Southern California (1736)
Tennessee (89)
Texas (741)
United States (17160)
Utah (113)
Vermont (1)
Virginia (97)
Washington D.C. (30)
Washington State (354)
West Virginia (4)
Wisconsin (68)
Wyoming (1)
319,104 Results for "alivamab discovery services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AlivaMab Biologics Announces Milestone- and Royalty-Free Access to AlivaMab(R) Mouse for Human Antibody Drug Discovery Services
September 3, 2025
·
2 min read
Press Releases
Ablexis Announces Validation and Availability of AlivaMab(R) Mouse-NGX
September 3, 2025
·
1 min read
Business
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities
Ablexis, LLC and AlivaMab Discovery Services, LLC announced an expansion of platforms and capabilities in antibody drug discovery and engineering.
November 15, 2022
·
4 min read
Business
AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer
AlivaMab Discovery Services, a leader in the discovery of superior antibody-based therapeutics, announced that Larry Green has reassumed the role of Chief Executive Officer, effective immediately.
September 23, 2022
·
2 min read
Business
AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences
AlivaMab Discovery Services, a leader in the discovery of superior antibody therapeutics, announced an expanded agreement with IGM Biosciences.
November 1, 2021
·
2 min read
Press Releases
Parse Biosciences Expands Global Access by Certifying Single Cell Discoveries as a Service Provider
October 1, 2025
·
2 min read
Press Releases
Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
December 24, 2025
·
3 min read
Business
AlivaMab Discovery Services Appoints Jane Seagal, PhD, as Vice President of Antibody Discovery
AlivaMab Discovery Services, LLC, a leader in the discovery of superior antibody-based therapeutics, announced Jane Seagal, PhD, has joined the company as Vice President of Antibody Discovery.
January 11, 2022
·
3 min read
Press Releases
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
November 18, 2025
·
5 min read
Business
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals Agreement aims to accelerate the discovery of new therapeutics
September 14, 2021
·
2 min read
1 of 31,911
Next
